echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > JAMA Sub-Journal: What are the consequences of discontinuing statins? The cardiovascular outcome will be worse!

    JAMA Sub-Journal: What are the consequences of discontinuing statins? The cardiovascular outcome will be worse!

    • Last Update: 2021-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Atherosclerotic cardiovascular disease (ASCVD) is a major disease that causes death in the elderly and affects the quality of life


    Recently, a study published in JAMA Network Open, a sub-journal of JAMA, showed that for people 65 years and older, if statins are stopped, the risk of fatal and non-fatal cardiovascular disease may be higher


    The researchers included 29047 residents ≥65 years of age from Italy who started taking statins, antihypertensive drugs, hypoglycemic drugs, and antihypertensive drugs without interruption from October 1, 2013 to January 31, 2015.


    The research team followed them up to June 30, 2018, during which 5819 people (20.


    The results found that compared with those who continued to take statins, patients who stopped taking statins had a 24% higher risk of hospitalization for heart failure (HR=1.


    The American Heart Association recommends that patients who need statin therapy should start taking statins before the age of 75, and continue to use them if they can tolerate them after the age of 75


    The "Chinese Expert Consensus on the Use of Statins in the Elderly with Dyslipidemia" also pointed out:

    Generally, the safety and tolerability of statins by the elderly are good


    Note: The original text has been deleted

    references:

    [1] Rea F, Biffi A, Ronco R, et al(2021).


    [2] Odds for death, hospital care rise when statins are stopped.


    [3] 2015 Chinese expert consensus on the use of statins in the elderly with dyslipidemia released.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.